Urinary bladder cancer antigen test in the diagnosis of recurrence after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma

Urinary bladder cancer antigen test in the diagnosis of recurrence after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma - UBC test as a marker for upper urinary tract urothelial carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006145

Enrollment

Registered

2011-08-10

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper urinary tract urothelial carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as upper urinary tract urothelial cancer and undergo radical nephroureterectomy

Exclusion criteria

Exclusion criteria: 1) History of bladder cancer or concomitant bladder cancer 2) Pathological diagnosis other than urothelial carcinoma 3) Residual tumor after radical nephroureterectomy 4) Patients who undergo systemic chemotherapy after radical nephroureterectomy

Design outcomes

Primary

Measure	Time frame
Detection of urinary recurrence	—

Countries

Japan

Contacts

Public ContactToshihiro Maeda

Sapporo Medical University School of Medicine Department of Urology

maeda-t@sapmed.ac.jp011-611-2111

Outcome results